Recent blog posts
Pearson syndrome Indication Strategy Report 2026: mtDNA, Trials and Deals
Latest Hotspot
8 min read
Pearson syndrome Indication Strategy Report 2026: mtDNA, Trials and Deals
30 July 2026
2026 Pearson syndrome indication strategy covering epidemiology, mtDNA biology, active trials, transactions, unmet need, competition and market attractiveness.
Read →
Barth syndrome Indication Strategy Report 2026: TAZ, Trials and Deals
Latest Hotspot
8 min read
Barth syndrome Indication Strategy Report 2026: TAZ, Trials and Deals
30 July 2026
2026 Barth syndrome indication strategy covering epidemiology, TAZ biology, active trials, transactions, unmet need, competition and market attractiveness.
Read →
Mitochondrial complex IV deficiency Indication Strategy Report 2026: SURF1, Trials and Deals
Latest Hotspot
8 min read
Mitochondrial complex IV deficiency Indication Strategy Report 2026: SURF1, Trials and Deals
30 July 2026
2026 Mitochondrial complex IV deficiency indication strategy covering epidemiology, SURF1 biology, active trials, transactions, unmet need, competition and…
Read →
Mitochondrial complex II deficiency Indication Strategy Report 2026: SDHA, Trials and Deals
Latest Hotspot
8 min read
Mitochondrial complex II deficiency Indication Strategy Report 2026: SDHA, Trials and Deals
30 July 2026
2026 Mitochondrial complex II deficiency indication strategy covering epidemiology, SDHA biology, active trials, transactions, unmet need, competition and market…
Read →
Multiple acyl-CoA dehydrogenase deficiency Indication Strategy Report 2026: ETFA, Trials and Deals
Latest Hotspot
8 min read
Multiple acyl-CoA dehydrogenase deficiency Indication Strategy Report 2026: ETFA, Trials and Deals
30 July 2026
2026 Multiple acyl-CoA dehydrogenase deficiency indication strategy covering epidemiology, ETFA biology, active trials, transactions, unmet need, competition and…
Read →
Mitochondrial complex I deficiency Indication Strategy Report 2026: NDUFS1, Trials and Deals
Latest Hotspot
8 min read
Mitochondrial complex I deficiency Indication Strategy Report 2026: NDUFS1, Trials and Deals
30 July 2026
2026 Mitochondrial complex I deficiency indication strategy covering epidemiology, NDUFS1 biology, active trials, transactions, unmet need, competition and…
Read →
Carnitine palmitoyltransferase I deficiency Indication Strategy Report 2026: CPT1A, Trials and Deals
Latest Hotspot
8 min read
Carnitine palmitoyltransferase I deficiency Indication Strategy Report 2026: CPT1A, Trials and Deals
30 July 2026
2026 Carnitine palmitoyltransferase I deficiency indication strategy covering epidemiology, CPT1A biology, active trials, transactions, unmet need, competition…
Read →
Carnitine-acylcarnitine translocase deficiency Indication Strategy Report 2026: SLC25A20, Trials and Deals
Latest Hotspot
8 min read
Carnitine-acylcarnitine translocase deficiency Indication Strategy Report 2026: SLC25A20, Trials and Deals
30 July 2026
2026 Carnitine-acylcarnitine translocase deficiency indication strategy covering epidemiology, SLC25A20 biology, active trials, transactions, unmet need,…
Read →
Trifunctional protein deficiency Indication Strategy Report 2026: HADHB, Trials and Deals
Latest Hotspot
8 min read
Trifunctional protein deficiency Indication Strategy Report 2026: HADHB, Trials and Deals
30 July 2026
2026 Trifunctional protein deficiency indication strategy covering epidemiology, HADHB biology, active trials, transactions, unmet need, competition and market…
Read →
Lactate dehydrogenase A deficiency Indication Strategy Report 2026: LDHA, Trials and Deals
Latest Hotspot
8 min read
Lactate dehydrogenase A deficiency Indication Strategy Report 2026: LDHA, Trials and Deals
30 July 2026
2026 Lactate dehydrogenase A deficiency indication strategy covering epidemiology, LDHA biology, active trials, transactions, unmet need, competition and market…
Read →
Short-chain acyl-CoA dehydrogenase deficiency Indication Strategy Report 2026: ACADS, Trials and Deals
Latest Hotspot
8 min read
Short-chain acyl-CoA dehydrogenase deficiency Indication Strategy Report 2026: ACADS, Trials and Deals
30 July 2026
2026 Short-chain acyl-CoA dehydrogenase deficiency indication strategy covering epidemiology, ACADS biology, active trials, transactions, unmet need, competition…
Read →
Phosphoglycerate mutase deficiency Indication Strategy Report 2026: PGAM2, Trials and Deals
Latest Hotspot
8 min read
Phosphoglycerate mutase deficiency Indication Strategy Report 2026: PGAM2, Trials and Deals
30 July 2026
2026 Phosphoglycerate mutase deficiency indication strategy covering epidemiology, PGAM2 biology, active trials, transactions, unmet need, competition and market…
Read →